| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_93f42eaa3ae7b0f778e0e922c293999f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-143333 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-43527 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-435 |
| filingDate |
2005-12-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_450462dd9d5d11006c58e4cb905471fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2687362c10b76e0c5be4b123f2219e94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_220de732a22e55b9cf7f8e93dfe28f0e |
| publicationDate |
2007-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1828234-A2 |
| titleOfInvention |
Cc-chemokine antagonists |
| abstract |
A novel CC-chemokine binding protein is isolated from the saliva of Rhipicephalus sanguineus. Compounds prepared in accordance with the present invention can be used as anti-inflammatory compounds and in the treatment or prevention of CC- chemokine-related diseases. |
| priorityDate |
2004-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |